1. Heparin beyond anti-coagulation
   Daohong Chen, 2021, Current Research in Translational Medicine CrossRef
2. Hypercoagulable State in COPD-A Comprehensive Literature Review
   Christos Kyriakopoulos et al, 2021, Diagnostics CrossRef
3. Abnormal expression and clinical value analysis of long noncoding RNA cancer susceptibility candidate 2 in children with severe pneumonia complicated with respiratory failure
   Jie Ni et al, 2022, The Clinical Respiratory Journal CrossRef
4. Optimal time to use low molecular weight heparin on prethrombotic state of rat chronic obstructive pulmonary disease model
   Wang Yanqing et al, 2014, Chinese Medical Journal CrossRef
5. Use of the Serum Level of Cholinesterase as a Prognostic Marker of Nonfatal Clinical Outcomes in Patients Hospitalized with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
   Zhixiang Chen et al, 2024, Canadian Respiratory Journal CrossRef
6. Benefits and risks of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials
   Mingjin Yang et al, 2020, Inflammopharmacology CrossRef
7. Differential proteomic analysis of respiratory failure in peripheral blood mononuclear cells using iTRAQ technology
   GUOPING SUN et al, 2016, Biomedical Reports CrossRef
8. Serum MCP-1 and NGAL Play an Important Role in the Acute Inflammatory Event of Chronic Obstructive Pulmonary Disease
   Xing-Ru Chen et al, 2021, COPD: Journal of Chronic Obstructive Pulmonary Disease CrossRef